Deutsche Bank’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$405K Buy
36,459
+3,079
+9% +$38.9K ﹤0.01% 2685
2025
Q4
$554K Buy
33,380
+3,808
+13% +$54.4K ﹤0.01% 2516
2025
Q3
$348K Buy
29,572
+3,493
+13% +$36K ﹤0.01% 2745
2025
Q2
$250K Sell
26,079
-1,093
-4% -$6.05K ﹤0.01% 2842
2025
Q1
$170K Sell
27,172
-3,041
-10% -$18.5K ﹤0.01% 3025
2024
Q4
$245K Buy
30,213
+9,986
+49% +$124K ﹤0.01% 3005
2024
Q3
$366K Buy
20,227
+5,156
+34% +$72.1K ﹤0.01% 2631
2024
Q2
$155K Buy
15,071
+809
+6% +$8.33K ﹤0.01% 2947
2024
Q1
$151K Sell
14,262
-3,437
-19% -$29.2K ﹤0.01% 2975
2023
Q4
$162K Buy
17,699
+4,870
+38% +$42K ﹤0.01% 2987
2023
Q3
$133K Buy
12,829
+1,700
+15% +$23.3K ﹤0.01% 3024
2023
Q2
$159K Sell
11,129
-5,070
-31% -$58.5K ﹤0.01% 3021
2023
Q1
$116K Buy
16,199
+5,356
+49% +$47K ﹤0.01% 3263
2022
Q4
$122K Buy
10,843
+152
+1% +$1.57K ﹤0.01% 3238
2022
Q3
$118K Buy
10,691
+542
+5% +$5.16K ﹤0.01% 3234
2022
Q2
$86K Sell
10,149
-1,392
-12% -$14.3K ﹤0.01% 3585
2022
Q1
$157K Sell
11,541
-1,298
-10% -$21K ﹤0.01% 3388
2021
Q4
$253K Buy
12,839
+642
+5% +$15.1K ﹤0.01% 3261
2021
Q3
$392K Sell
12,197
-372
-3% -$12.4K ﹤0.01% 3191
2021
Q2
$425K Buy
12,569
+5,144
+69% +$184K ﹤0.01% 3326
2021
Q1
$279K Sell
7,425
-657
-8% -$27.5K ﹤0.01% 3454
2020
Q4
$268K Buy
8,082
+2,071
+34% +$83.9K ﹤0.01% 3301
2020
Q3
$220K Buy
6,011
+520
+9% +$18K ﹤0.01% 3164
2020
Q2
$181K Buy
5,491
+1,781
+48% +$68.4K ﹤0.01% 3186
2020
Q1
$96K Sell
3,710
-216
-6% -$7.22K ﹤0.01% 3271
2019
Q4
$121K Buy
+3,926
New +$98.7K ﹤0.01% 3493

Other funds holding PHAT